How Is Iron Processed in the Human Body?

Explore the complex process of iron metabolism in the human body, vital for health and carefully regulated.

Iron processing in the human body is a tightly controlled loop of absorption, transport, storage, and recycling, with almost no mechanism for deliberately excreting excess iron. Of the roughly 7 mg of iron in a typical day’s food, only about 1 to 2 mg actually crosses the gut lining into the bloodstream, making absorption the body’s primary gatekeeper for how much iron enters the system. Once inside, about 70% of the body’s iron ends up in hemoglobin, the molecule in red blood cells that carries oxygen, with the rest distributed among storage proteins, muscle tissue, and enzymes. The system is surprisingly closed, relying heavily on internal recycling rather than fresh dietary supply.

How Iron Gets Absorbed from Food

Iron enters your body through specialized cells lining the upper part of your small intestine, primarily in the duodenum and the beginning of the jejunum. These cells act like selective filters, pulling iron from digested food and passing it into the blood. Two forms of dietary iron exist: heme iron, which comes from animal-based foods and is already wrapped in a molecular structure the gut can absorb relatively easily, and nonheme iron, found in plants, grains, and fortified foods. Each form uses a different molecular pathway to cross the intestinal wall, but once inside the cell, both end up in the same pool, available for storage or export into circulation.

What you eat alongside iron-containing foods matters a lot for nonheme absorption. Vitamin C and animal proteins can boost nonheme iron absorption by as much as four times. On the other hand, compounds like phytates (concentrated in whole grains and legumes), polyphenols (in tea, coffee, and some fruits), and calcium can substantially reduce how much nonheme iron your gut absorbs. Your body’s existing iron stores also influence absorption: when stores are low, the gut ramps up its uptake; when stores are full, it dials down.

Transport Through the Bloodstream

Once iron crosses the intestinal cell and exits into the blood, it needs a chaperone. Free iron floating around in plasma would be chemically reactive and potentially damaging. Instead, iron binds to a protein called transferrin, which shuttles it through the bloodstream to wherever it is needed. Developing red blood cells are the biggest consumers. They pull in transferrin-bound iron through receptors on their surface, strip the iron off inside the cell, and use it to build hemoglobin. Iron that isn’t immediately used for hemoglobin gets stored inside the cell as ferritin until it’s needed.

Transferrin doesn’t just serve the bone marrow. It delivers iron to virtually every tissue in the body, including the liver, muscles, and the brain, though each destination has its own rules for how it takes iron in. The liver, for instance, acts as the body’s main iron warehouse, storing large quantities in ferritin. Muscles use iron in a protein called myoglobin, which holds oxygen reserves for use during exertion.

How Iron Is Stored

Ferritin is the body’s iron storage protein. It works like a molecular cage: 24 protein subunits assemble into a hollow shell that can hold up to about 4,500 iron atoms in its core. This design keeps stored iron chemically inert, locked away in a stable mineral form so it cannot participate in harmful reactions. When a cell or the body at large needs more iron, ferritin releases it from its core back into the active pool.

Ferritin levels measured in a blood test reflect the body’s iron reserves, which is why doctors use it as a first-line screening tool. Low ferritin usually signals depleted iron stores well before full-blown anemia develops. However, ferritin is also what’s called an acute-phase reactant, meaning its levels can rise during infection, inflammation, or chronic disease regardless of how much iron is actually stored. This complication can mask genuine iron deficiency in people who are sick.

The Hepcidin System and Whole-Body Regulation

The liver acts as the central command for iron balance, largely through a small peptide hormone called hepcidin. Hepcidin is produced by liver cells and released into the bloodstream in response to iron levels and inflammatory signals. Its target is ferroportin, the only known protein that can export iron out of cells and into the blood. Ferroportin sits on the surface of intestinal cells, liver storage cells, and the recycling macrophages that break down old red blood cells.

When hepcidin binds to ferroportin, ferroportin gets pulled inside the cell and destroyed. Without ferroportin on the cell surface, iron becomes trapped inside those cells and cannot enter the blood. This is how the body slows iron absorption when stores are already full: hepcidin goes up, ferroportin goes down, and less dietary iron makes it past the intestinal wall.

Hepcidin levels respond to several signals. High body iron and inflammation both increase hepcidin production. Conditions that ramp up red blood cell production, like altitude exposure, blood loss, or pregnancy, suppress hepcidin so more iron flows into the blood for hemoglobin manufacture. This dual responsiveness is elegant but creates a real problem during infections: inflammation drives hepcidin up, trapping iron inside cells, which starves both pathogens and your own red blood cell production at the same time. The resulting “anemia of chronic disease” is one of the most common anemias worldwide and is not caused by a lack of dietary iron.

How Cells Fine-Tune Their Own Iron

Beyond hepcidin acting at the whole-body level, individual cells have their own iron-sensing system. Proteins called iron regulatory proteins (IRP1 and IRP2) monitor iron levels inside each cell. When iron is scarce, these proteins bind to specific loops in the genetic instructions for iron-related proteins, adjusting which proteins the cell makes more or less of. The practical effect is that a cell running low on iron will increase its production of transferrin receptors (to grab more iron from the blood) while decreasing its production of ferritin (because there’s no surplus to store). When iron is abundant, the opposite happens.

This cellular thermostat works independently in every cell of the body, allowing different tissues to adjust their iron handling based on local conditions. A muscle cell working hard and consuming more oxygen may need more iron than a resting one; a liver cell storing surplus iron may need to ramp up ferritin production. The whole-body hepcidin system and the cell-by-cell IRP system run in parallel, creating a two-tiered regulatory scheme.

Recycling Old Red Blood Cells

The single largest source of iron in your blood at any given time is not your diet. It’s recycled iron. Red blood cells live roughly 120 days, and when they reach the end of their lifespan, specialized immune cells called macrophages, concentrated in the spleen and liver, engulf and break them down. The hemoglobin is dismantled, and the iron is extracted and either stored within the macrophage or exported back into circulation via ferroportin to be loaded onto transferrin again.

This recycling operation recovers the vast majority of the iron the body uses every day, dwarfing the 1 to 2 mg arriving from the gut. Because the system is so efficient at reclaiming iron, and because mammals have no dedicated excretion pathway for excess iron, the body operates almost as a closed loop. Small amounts of iron leave through shed skin cells, intestinal lining turnover, and trace urinary losses, but these are passive and uncontrolled. Menstruation represents the only substantial regular iron loss, which is why premenopausal women are at significantly higher risk of deficiency than men of the same age.

Why Free Iron Is Dangerous

All the careful shuttling, chaperoning, and caging of iron exists for a reason: loose iron is chemically destructive. When iron isn’t bound to transferrin, ferritin, or another protein, it can react with hydrogen peroxide, a normal byproduct of cellular metabolism, to produce hydroxyl radicals. These are among the most reactive molecules in biology, capable of tearing apart DNA, proteins, and cell membranes. This chain of reactions, known as Fenton chemistry, is the core reason the body never lets iron float around unescorted.

Iron-driven oxidative damage has been linked to aging processes and neurodegenerative conditions. In the brain, iron accumulates in certain regions as people age, and elevated iron in the basal ganglia is associated with Parkinson’s and Alzheimer’s disease. Whether brain iron accumulation is a cause or a consequence of neurodegeneration remains an active area of research, but the relationship is consistent enough to drive interest in iron-targeting therapies for these conditions.

Ferroptosis and Iron-Dependent Cell Death

Researchers have identified a form of cell death that depends specifically on iron: ferroptosis. Unlike the tidy, programmed cell death the body normally uses to remove old or damaged cells, ferroptosis involves a runaway chain of iron-catalyzed damage to the fats in cell membranes. When enough of these membrane fats are oxidized, the cell essentially ruptures. The two key triggers are intracellular iron accumulation and failure of the cell’s antioxidant defenses that normally neutralize oxidized lipids.

Ferroptosis has become one of the hotter topics in biomedical research because it appears to play roles in cancer, organ injury after a heart attack or stroke, and kidney disease. Iron chelators, drugs that bind and neutralize free iron, can prevent ferroptosis in experimental settings, which has spurred interest in ferroptosis-targeting treatments. The connection between everyday iron metabolism and this cell death pathway underscores why the body invests so much machinery in keeping iron tightly controlled at every level.

Iron and the Immune System

Nearly all bacteria and other pathogens that infect humans require iron to grow. Your immune system exploits this dependency through a strategy called nutritional immunity: during infection, the body actively hides its iron to starve the invaders. This is partly why hepcidin surges during inflammation. By pulling ferroportin off cell surfaces, the body traps iron inside macrophages and other storage cells, denying it to circulating microbes.

This defense strategy is effective, but it comes at a cost. If the infection is prolonged or the inflammation becomes chronic, the iron lockdown persists, and your bone marrow is starved of the iron it needs to produce red blood cells. The result is anemia that looks like iron deficiency on the surface but doesn’t respond to iron supplements because the problem isn’t a lack of iron in the body. It’s iron being deliberately withheld from circulation. This distinction matters clinically, because giving iron supplements to someone with infection-driven anemia can actually feed the pathogen rather than fix the anemia.

Iron in the Brain

The brain has its own tightly controlled iron economy, largely because the blood-brain barrier limits what can pass from the general circulation into brain tissue. Iron crosses this barrier primarily through transferrin receptors on the endothelial cells that line brain blood vessels. Iron-loaded transferrin is pulled into these cells, iron is released inside, and then exported on the other side into the brain’s interstitial fluid. Some iron also crosses as non-transferrin-bound iron through a separate pathway.

Once inside the brain, iron is essential for synthesizing myelin (the insulation around nerve fibers), producing certain neurotransmitters, and supporting the energy-generating machinery in neurons. Iron in the brain tends to accumulate with age, particularly in the basal ganglia, and elevated brain iron is a consistent finding in Parkinson’s and Alzheimer’s disease. On the other end of the spectrum, iron deficiency during early development is associated with cognitive and behavioral impairments, some of which may not fully reverse even after iron levels are corrected. The brain’s dependence on iron is a double-edged sword: too little impairs function, too much promotes damage.

Iron in Mitochondria

Inside individual cells, mitochondria are the main consumers of iron. They import iron through a dedicated transport protein called mitoferrin and use it to build two critical types of molecules: iron-sulfur clusters and heme. Iron-sulfur clusters are essential components of the electron transport chain, the process by which mitochondria generate the cell’s energy currency. Heme, beyond its role in hemoglobin within red blood cells, also functions inside mitochondria as part of the enzymes that handle oxygen during energy production.

Because mitochondria need a constant supply of iron and also handle highly reactive oxygen, they are a natural hotspot for iron-related oxidative damage if regulation falters. Defects in mitochondrial iron handling have been linked to rare genetic disorders, most notably Friedreich’s ataxia, in which iron accumulates inside mitochondria of nerve and heart cells, progressively damaging them.

Iron During Pregnancy

Pregnancy dramatically reshapes iron metabolism. The placenta actively transports iron from maternal blood to the developing fetus using the same molecular toolkit found elsewhere in the body: transferrin receptors on the maternal-facing side pull iron in, and ferroportin on the fetal-facing side exports it. When a mother’s iron levels drop, the placenta compensates by increasing the production of both these transporters, ensuring the fetus continues to receive iron even at the mother’s expense.

Maternal hepcidin plays a regulatory role here too: high hepcidin in the mother’s blood reduces ferroportin expression in the placenta, throttling back iron transfer to the fetus. This means that conditions causing chronically elevated maternal hepcidin, such as infections or inflammatory disorders, could theoretically limit fetal iron supply even when the mother’s total iron stores are adequate. Maternal hepcidin levels naturally decline during the second and third trimesters, a built-in adaptation that opens the iron pipeline as fetal demand peaks.

What Goes Wrong in Iron Overload

Because the body has no active way to dump excess iron, the only protection against overload is limiting how much gets in. When that gatekeeper system fails, iron accumulates relentlessly. The most common genetic cause is hereditary hemochromatosis, a condition in which hepcidin production is deficient or ineffective, leaving ferroportin chronically active and allowing too much iron to pour into the blood from both the gut and recycling macrophages. The excess iron deposits in the liver, heart, and pancreas, eventually causing cirrhosis, heart failure, and diabetes if untreated.

Iron overload also occurs in people who receive repeated blood transfusions, such as those with sickle cell disease or thalassemia. Each unit of transfused blood carries a significant iron payload, and the body simply has no way to get rid of it. These patients often require iron chelation therapy, medications that bind circulating iron and allow it to be excreted through the kidneys or stool, essentially creating the excretion pathway the body never evolved on its own.

Iron Deficiency and Why It’s So Common

Iron deficiency anemia occurs when the balance of iron intake, iron stores, and iron losses can no longer support adequate red blood cell production. It is the most common nutritional deficiency worldwide, affecting hundreds of millions of people. The reasons are straightforward given everything above: the gut absorbs only a small fraction of dietary iron, nonheme iron absorption is easily inhibited by common dietary components, and the body’s only significant excretion route is uncontrolled blood loss.

Groups at highest risk include premenopausal women (due to menstrual losses), pregnant women (due to massive fetal demands), growing children, and people with gastrointestinal conditions that impair absorption. Symptoms include fatigue, weakness, pale skin, cold hands and feet, and difficulty concentrating. Because the body depletes its ferritin stores before hemoglobin levels fall, iron deficiency exists on a spectrum: you can be iron-depleted with normal hemoglobin, or you can progress to full anemia where both stores and circulating hemoglobin are low.

Unabsorbed Iron and the Gut Microbiome

Not all dietary iron gets absorbed in the upper small intestine. The fraction that passes through unabsorbed eventually reaches the colon, where it encounters the dense community of gut bacteria. Iron is essential for most of these microbes, so its availability in the colon directly shapes the composition of the gut microbiome. This creates a somewhat uncomfortable situation for iron supplementation: taking high-dose oral iron supplements to correct deficiency floods the colon with unabsorbed iron, which can promote the growth of potentially harmful bacteria while suppressing beneficial species. Many people on oral iron supplements experience gastrointestinal side effects like constipation, nausea, and bloating, and the microbiome disruption may be a contributing factor. Lower-dose or alternate-day supplementation strategies have gained attention in recent years partly because they may reduce this gut impact while still correcting iron stores, since the gut’s absorption machinery seems to reset between doses.